India’s Serum to double investment in Biocon’s unit to $300 mln

Synopsis Serum Institute of Life Sciences is a unit of Serum Institute of India, the world’s biggest vaccine maker. Under new terms of the alliance, it would pump in $150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd, the company said. Serum to double investment in Biocon’s unit to $300 mn; aim to generate higher EBITDA going ahead: Kiran Mazumdar-Shaw The Serum Institute of Life Sciences will double its investment in one of Biocon Ltd ‘s units, giving it access to 100 million doses of vaccines annually along with the distribution rights to Serum’s vaccine portfolio, the Indian biopharma firm said on Tuesday.

Serum Institute of Life Sciences is a unit of Serum Institute of India, the world’s biggest vaccine maker. Under new terms of the alliance, it would pump in $150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd, the company said. The investment is in addition to the $150 million that Serum Institute of Life Sciences invested in Biocon Biologics in November, the company said.

Biocon had signed an agreement in September 2021 to offer about 15% stake in Biocon Biologics to Serum Institute of Life Sciences. Don’t miss out on ET Prime stories! Get your daily dose of business updates on WhatsApp. click here! In Video: Serum to double investment in Biocon’s unit to $300 mn; aim to generate higher EBITDA going ahead: Kiran Mazumdar-Shaw Tuesday, 25 Apr, 2023 Experience Your Economic Times Newspaper, The Digital Way! Read Complete Print Edition » Front Page Pure Politics Companies Brands & Companies More Startups Call for Exempting More from Angel Tax The startup industry is lobbying the finance ministry to scrap, or at least increase, the ₹25-crore paid-up capital threshold for exemption from the so-called angel tax.

Vedanta Resources Clears Apr Dues, Cuts Debt by $1b London-based Vedanta Resources (VRL), the parent company of India-listed Vedanta Ltd (VDL), said on Monday that it had paid off loans and bonds due in April and reduced gross debt by $1 billion. Pvt Sector Capex in Focus at ET Awards Prime Minister Narendra Modi wants Indian industry to unleash its animal spirits, building on the investment thrust led by the Centre that’s seeing a vast infrastructure buildout across the country. Read More News on Serum Institute of Life Sciences Serum Biocon vaccine Biocon Pharma Ltd biocon ltd biocon (Catch all the Business News , Breaking News Events and Latest News Updates on The Economic Times .

) Download The Economic Times News App to get Daily Market Updates & Live Business News. . .

. more less ETPrime stories of the day FMCG What is contributing to Nestlé India’s market dominance? No, it’s not Maggi but Cerelac. 10 mins read Deals Q1 CY23 sees more mid-market and traditional sector M&As as overall deal activity drops.

8 mins read Pharma Mankind Pharma IPO: Reasonably priced, investors may join the company on its ‘Bharat-to-India’ quest 7 mins read Subscribe to ETPrime.